Skip to main content

Table 1 Patient characteristics and univariate analysis

From: The prognostic influence of body mass index, resting energy expenditure and fasting blood glucose on postoperative patients with esophageal cancer

Factors

 

N

5-year survival (%)

p

Age, year

≤65

210

53.3

0.003

>65

96

34.6

 

Sex

Male

235

44.0

0.039

Female

71

57.8

 

Histology

AC

98

49.7

0.590

SCC

208

45.7

 

Surgical type

Transthoracic

186

47.0

0.701

McKeown

53

40.4

 

Transabdominal

67

51.2

 

Differentiation

Well

38

61.9

0.000

Moderately

173

55.1

 

Poorly

95

24.9

 

T stage

Tis/T1

31

82.2

0.000

T2

65

62.1

 

T3

159

43.3

 

T4a

51

17.1

 

N stage

N0

156

67.5

0.000

N1

73

38.6

 

N2

52

14.2

 

N3-4

25

9.5

 

TNM stage

0-I

42

80.5

0.000

II

118

66.5

 

III

146

21.3

 

Weight lost

No/Little

203

46.5

0.555

Middle

50

56.8

 

Large

53

41.7

 

Adjuvant Chemoradiation

Yes

78

41.7

0.187

No

228

48.8

 

Albumin

<35 g/l

36

26.7

0.000

35–40 g/l

132

41.6

 

>40 g/l

138

57.8

 

Lymphocyte

<1.1*109

42

48.7

0.780

1.1–3.2*109

228

47.5

 

>3.2*109

36

42.6

 

NLR

<5

289

47.1

0.787

≥5

17

47.1

 

REE/kg

<23.2

245

50.4

0.024

≥23.2

61

35.2

 

REE

Low

154

40.4

0.010

High

152

55.3

 

FBG

Low

108

35.0

0.020

High

198

51.7

 

BMI

Low

81

36.8

0.046

Normal

186

49.1

 

High

39

62.8

 
  1. CI confidence interval, OR odds ratio
  2. The results were in bold, if the 95 % CI excluded 1 or p<0.05